Rockefeller Capital Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5K Sell
97
-24
-20% -$556 ﹤0.01% 4377
2026
Q1
$2.49K Sell
121
-290
-71% -$6.54K ﹤0.01% 4375
2025
Q4
$9.74K Sell
411
-203
-33% -$4.94K ﹤0.01% 3817
2025
Q3
$15.3K Buy
+614
New +$13.2K ﹤0.01% 3475
2022
Q3
– Sell
-596
Closed -$17K – 4284
2022
Q2
$17K Sell
596
-404
-40% -$10.3K ﹤0.01% 2836
2022
Q1
$26K Hold
1,000
– – ﹤0.01% 2606
2021
Q4
$25K Buy
+1,000
New +$24.9K ﹤0.01% 2543

Other funds holding PRVA

Rockefeller Capital Management's PRVA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Privia Health (PRVA) stake by 20% in Q2 2026, selling an estimated $556 and leaving 97 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4377.

Rockefeller Capital Management first reported a position in PRVA in Q4 2021 and has held it in 7 quarters since. The position peaked at $26K in Q1 2022. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Rockefeller Capital Management held 97 shares of Privia Health worth $2.5K as of Q2 2026.
  • Rockefeller Capital Management sold 24 Privia Health shares in Q2 2026, an estimated $556.
  • Privia Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4377 holding.
  • Rockefeller Capital Management first reported a position in Privia Health in Q4 2021 and has held it in 7 quarters since.
  • Rockefeller Capital Management's Privia Health position peaked at $26K in Q1 2022.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.